Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.32 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.32 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL5644122 | 0.87 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL575704 | 0.83 | CA1 (0.33) | ALDH1A1CA1CA2CA9CA7 | |
| SCHEMBL14779233 | 0.83 | CA1 (0.43) | ALDH1A1CA1CA2CA9CA7 | |
| SCHEMBL778307 | 0.81 | CA1 (0.32) | ALDH1A1CA1CA2CA9CA7 | |
| SCHEMBL1759309 | 0.81 | CA1 (0.32) | ALDH1A1CA1CA2CA9CA7 | |
| SCHEMBL28926829 | 0.80 | — | — | |
| SCHEMBL28896513 | 0.80 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL15282823 | 0.79 | CA1 (0.36) | ALDH1A1CA1CA2CA9CA7 | |
| SCHEMBL21801671 | 0.79 | ALDH1A1 (0.36) | ALDH1A1CA1CA2CA9CXCR2 | |
| SCHEMBL21801399 | 0.79 | ALDH1A1 (0.36) | ALDH1A1CA1CA2CA9CXCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025099634-A1 | PROCESS FOR PREPARING THE POLYMORPHIC FORM III OF TAPINAROF | PROCOS S.P.A. (IT) | 2025-05-15 | — | — | WO | claimed |
| CN-119372649-A | Compatible display panel aluminum etching solution, and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-117039163-A | Lithium ion battery electrolyte and lithium ion battery | 中国科学技术大学 | 2023-11-10 | — | — | CN | claimed |
| CN-116003429-A | Preparation method of 9, 9-bis (trifluoromethyl) -2,3,6, 7-xanthene tetracarboxylic dianhydride | 陕西泰合利华工业有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-105085264-A | Asymmetric synthesis method for tanshinol ester derivative | UNIV SHANGHAI JIAOTONG | 2015-11-25 | — | — | CN | claimed |
| EP-1077926-B1 | PROPYLISOPROPYL ACETAMIDE STEREOISOMERS, A METHOD FOR THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RES DEV CO (IL) | 2005-02-23 | — | — | EP | claimed |
| US-20030212131-A1 | Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them | BIALER MEIR (IL) | 2003-11-13 | — | — | US | claimed |
| US-6630602-B1 | Racemic propylisopropyl acetic acid and propylisopropyl acetamide and their isomers in their racemic and stereospecific forms, for use in treatment of neurological and psychotic disorders, and affective disorders and to treat | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2003-10-07 | — | — | US | claimed |
| EP-1077926-A1 | PROPYLISOPROPYL ACETIC ACID AND PROPYLISOPROPYL ACETAMIDE STEREOISOMERS, A METHOD FOR THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2001-02-28 | — | — | EP | claimed |
| WO-1999054282-A1 | PROPYLISOPROPYL ACETIC ACID AND PROPYLISOPROPYL ACETAMIDE STEREOISOMERS, A METHOD FOR THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY (IL) | 1999-10-28 | — | — | WO | claimed |
| US-12612391-B2 | Cromolyn derivatives and uses thereof | THE GENERAL HOSPITAL CORPORATION (US) | 2026-04-28 | — | — | US | disclosed |
| US-12605471-B2 | Cromolyn derivatives and related methods of imaging and treatment | THE GENERAL HOSPITAL CORPORATION (US) | 2026-04-21 | — | — | US | disclosed |
| US-12383528-B2 | Cromolyn esters and uses thereof | THE GENERAL HOSPITAL CORPORATION (US) | 2025-08-12 | — | — | US | disclosed |
| EP-4577524-A1 | METHODS OF MANUFACTURING KINASE INHIBITORS | Insilico Medicine IP Limited (HK) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025099634-A1 | PROCESS FOR PREPARING THE POLYMORPHIC FORM III OF TAPINAROF | PROCOS S.P.A. (IT) | 2025-05-15 | — | — | WO | disclosed |
| EP-0569046-A1 | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension | Pharmacia AB (SE) | 1993-11-10 | — | — | EP | disclosed |
| US-5153180-A | Used for treating aids | BURROUGHS WELLCOME CO. | 1992-10-06 | — | — | US | disclosed |
| EP-0364417-A1 | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension | Pharmacia AB (SE) | 1990-04-18 | — | — | EP | disclosed |
| WO-1990002553-A1 | PROSTAGLANDIN DERIVATIVES FOR THE TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION | PHARMACIA AB (SE) | 1990-03-22 | — | — | WO | disclosed |
| US-4165332-A | Preparation of aliphatic perchlorates and of trifluoromethane sulfonates | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1979-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605471-B2 | Cromolyn derivatives and related methods of imaging and treatment | PSEN1, APP, PSEN2 | ALDH1A1 3176/4885CA1 49/4885CA2 245/4885 |
| US-12612391-B2 | Cromolyn derivatives and uses thereof | HTT, PRNP, PSEN1 | ALDH1A1 3162/4885CA1 826/4885CA2 355/4885 |
| US-20030212131-A1 | Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them | ADCYAP1R1, GRIN2A, PTGER1 | ALDH1A1 171/4885CA1 1049/4885CA2 1385/4885 |
| US-12383528-B2 | Cromolyn esters and uses thereof | PRNP, HTT, PSEN1 | ALDH1A1 1915/4885CA1 873/4885CA2 4251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.